GLP-1 signaling has been demonstrated to improve cardiac function in several animal model experiments, such as endotoxemia, myocardial infarction, and diabetic cardiomyopathy [11], [13]–[18]. Here, GLP1R is linked to serum lipopolysaccharide activity.